[HTML][HTML] Ocular drug delivery to the retina: current innovations and future perspectives
HM Kim, SJ Woo - Pharmaceutics, 2021 - mdpi.com
Treatment options for retinal diseases, such as neovascular age-related macular
degeneration, diabetic retinopathy, and retinal vascular disorders, have markedly expanded …
degeneration, diabetic retinopathy, and retinal vascular disorders, have markedly expanded …
[HTML][HTML] Recent advances of ocular drug delivery systems: prominence of ocular implants for chronic eye diseases
Chronic ocular diseases can seriously impact the eyes and could potentially result in
blindness or serious vision loss. According to the most recent data from the WHO, there are …
blindness or serious vision loss. According to the most recent data from the WHO, there are …
Progress in nanomedicine-based drug delivery in designing of chitosan nanoparticles for cancer therapy
MZ Ahmad, M Rizwanullah, J Ahmad… - … Journal of Polymeric …, 2022 - Taylor & Francis
Cancer is among the most dreadful fatal diseases globally, and the efficacy of recent
chemotherapeutic approaches is limited due to many related drawbacks. The major …
chemotherapeutic approaches is limited due to many related drawbacks. The major …
Anti-angiogenic carbon nanovesicles loaded with bevacizumab for the treatment of age-related macular degeneration
A Anand, HJ Jian, HH Huang, LE Hean, YJ Li, JY Lai… - Carbon, 2023 - Elsevier
Intraocular angiogenesis mediated by vascular endothelial growth factor (VEGF) and the
related ocular disease, age-related macular degeneration (AMD), is the leading cause of …
related ocular disease, age-related macular degeneration (AMD), is the leading cause of …
[HTML][HTML] Nanodelivery of resveratrol-loaded PLGA nanoparticles for age-related macular degeneration
P Bhatt, G Fnu, D Bhatia, A Shahid, V Sutariya - AAPS PharmSciTech, 2020 - Springer
Age-related macular degeneration, precisely neovascular form, is the leading cause of
vision loss and the key treatment includes intravitreal injections of anti-vascular endothelial …
vision loss and the key treatment includes intravitreal injections of anti-vascular endothelial …
[HTML][HTML] Boosting the anticancer activity of sunitinib malate in breast cancer through lipid polymer hybrid nanoparticles approach
In the current study, lipid-polymer hybrid nanoparticles (LPHNPs) fabricated with lipoid-90H
and chitosan, sunitinib malate (SM), an anticancer drug was loaded using lecithin as a …
and chitosan, sunitinib malate (SM), an anticancer drug was loaded using lecithin as a …
Emerging therapies and their delivery for treating age‐related macular degeneration
Age‐related macular degeneration (AMD) is the most common cause of blindness in the
Western world and is characterised in its latter stages by retinal cell death and …
Western world and is characterised in its latter stages by retinal cell death and …
[HTML][HTML] Pluronic F-127/silk fibroin for enhanced mechanical property and sustained release drug for tissue engineering biomaterial
Herein, an injectable thermosensitive hydrogel was developed for a drug and cellular
delivery system. The composite was prepared by facile physical mixing of pluronic F-127 …
delivery system. The composite was prepared by facile physical mixing of pluronic F-127 …
Disease progression pathways of wet AMD: opportunities for new target discovery
Introduction Age-related macular degeneration (AMD) is the leading cause of irreversible
blindness among people age 60 years or older in developed countries. Current standard-of …
blindness among people age 60 years or older in developed countries. Current standard-of …
Long-acting formulation strategies for protein and peptide delivery in the treatment of PSED
The invigoration of protein and peptides in serious eye disease includes age-related
macular degeneration, choroidal neovascularization, retinal neovascularization, and …
macular degeneration, choroidal neovascularization, retinal neovascularization, and …